Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
Summary
- Conditions
- Cardiovascular Diseases
- Degenerative Mitral Valve Disease
- Functional Mitral Regurgitation
- Heart Valve Diseases
- Mitral Insufficiency
- Mitral Regurgitation
- Mitral Valve Insufficiency
- Valve Disease, Heart
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03433274
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Gorav Ailawadi, MD University of Michigan Principal Investigator: Jason Rogers, MD University of California, Davis Study Director: Kartik Sundareswaran, PhD Abbott Structural Heart